T cell vaccination induces the elimination of EAE effector T cells: Analysis using GFP-transduced, encephalitogenic T cells

Journal of Autoimmunity

Volumn 35, Issue 2, 2010, Pages 135-144

  Volovitz, Ilan ^a,b   Marmor, Yotvat ^a   Mor, Felix ^a   Flügel, Alexander ^c,d   Odoardi, Francesca ^c,d   Eisenbach, Lea ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b The Department of Neurosurgery   (Israel)

^c MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cell tracking methods; Experimental autoimmune encephalomyelitis EAE; Multiple sclerosis MS; Rodent rat; T cell vaccination TCV; T cells

Indexed keywords

GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; OVALBUMIN;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; IN VIVO STUDY; LYMPHOCYTE COUNT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; THYMUS; VACCINATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL LINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; SPINAL CORD; T-LYMPHOCYTES; VACCINATION;

EID: 77955924027     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.05.003     Document Type: Article

References (47)

1. Ben-Nun A., Wekerle H., Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981, 11:195-199.
2. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J Exp Med 2001, 194:F27-30.
3. Naparstek Y., Ben-Nun A., Holoshitz J., Reshef T., Frenkel A., Rosenberg M., et al. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol 1983, 13:418-423.
4. Vandenbark A.A., Abulafia-Lapid R. Autologous T-cell vaccination for multiple sclerosis: a perspective on progress. BioDrugs 2008, 22:265-273.
5. Correale J., Farez M., Gilmore W. Vaccines for multiple sclerosis: progress to date. CNS Drugs 2008, 22:175-198.
6. Ben-Nun A., Wekerle H., Cohen I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 1981, 292:60-61.
7. Holoshitz J., Naparstek Y., Ben-Nun A., Cohen I.R. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983, 219:56-58.
8. Maron R., Zerubavel R., Friedman A., Cohen I.R. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol 1983, 131:2316-2322.
9. Kakimoto K., Katsuki M., Hirofuji T., Iwata H., Koga T. Isolation of T cell line capable of protecting mice against collagen-induced arthritis. J Immunol 1988, 140:78-83.
10. Beraud E., Kotake S., Caspi R.R., Oddo S.M., Chan C.C., Gery I., et al. Control of experimental autoimmune uveoretinitis by low dose T cell vaccination. Cell Immunol 1992, 140:112-122.
11. Ben-Yehuda A., Bar-Tana R., Livoff A., Ron N., Cohen I.R., Naparstek Y. Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice. Lupus 1996, 5:232-236.
12. Elias D., Tikochinski Y., Frankel G., Cohen I.R. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide. Int Immunol 1999, 11:957-966.
13. Chen G., Li N., Zang Y.C., Zhang D., He D., Feng G., et al. Vaccination with selected synovial T cells in rheumatoid arthritis. Arthritis Rheum 2007, 56:453-463.
14. Li Z.G., Mu R., Dai Z.P., Gao X.M. T cell vaccination in systemic lupus erythematosus with autologous activated T cells. Lupus 2005, 14:884-889.
15. Lider O., Reshef T., Beraud E., Ben-Nun A., Cohen I.R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988, 239:181-183.
16. Kumar V., Stellrecht K., Sercarz E. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J Exp Med 1996, 184:1609-1617.
17. Kumar V., Sercarz E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J Immunol 1998, 161:6585-6591.
18. Sun D., Qin Y., Chluba J., Epplen J.T., Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988, 332:843-845.
19. Panoutsakopoulou V., Huster K.M., McCarty N., Feinberg E., Wang R., Wucherpfennig K.W., et al. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J Clin Invest 2004, 113:1218-1224.
20. Jiang H., Kashleva H., Xu L.X., Forman J., Flaherty L., Pernis B., et al. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci U S A 1998, 95:4533-4537.
21. Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008, 195:121-134.
22. Mor F., Reizis B., Cohen I.R., Steinman L. IL-2 and TNF receptors as targets of regulatory T-T interactions: isolation and characterization of cytokine receptor-reactive T cell lines in the Lewis rat. J Immunol 1996, 157:4855-4861.
23. Lohse A.W., Mor F., Karin N., Cohen I.R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 1989, 244:820-822.
24. Zhang J., Medaer R., Stinissen P., Hafler D., Raus J. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993, 261:1451-1454.
25. Weinberg A.D., Celnik B., Vainiene M., Buenafe A.C., Vandenbark A.A., Offner H. The effect of TCR V beta 8 peptide protection and therapy on T cell populations isolated from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 1994, 49:161-170.
26. Zhou S.R., Whitaker J.N., Han Q., Maier C., Blalock J.E. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2. J Immunol 1994, 153:2340-2351.
27. Naparstek Y., Holoshitz J., Eisenstein S., Reshef T., Rappaport S., Chemke J., et al. Effector T lymphocyte line cells migrate to the thymus and persist there. Nature 1982, 300:262-264.
28. Flugel A., Bradl M. New tools to trace populations of inflammatory cells in the CNS. Glia 2001, 36:125-136.
29. Flugel A., Willem M., Berkowicz T., Wekerle H. Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 1999, 5:843-847.
30. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14:547-560.
31. Bubnic S.J., Nagy A., Keating A. Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients. Hematology 2005, 10:289-295.
32. Kawakami N., Lassmann S., Li Z., Odoardi F., Ritter T., Ziemssen T., et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 2004, 199:185-197.
33. Reizis B., Schramm C., Cohen I.R., Mor F. Expression of major histocompatibility complex class II molecules in rat T cells. Eur J Immunol 1994, 24:2796-2802.
34. Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001, 36:118-124.
35. Samoilova E.B., Horton J.L., Zhang H., Chen Y. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J Mol Med 1997, 75:603-608.
36. Takeuchi H., Wang J., Kawanokuchi J., Mitsuma N., Mizuno T., Suzumura A. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol Dis 2006, 22:33-39.
37. Steinman L. A rush to judgment on Th17. J Exp Med 2008, 205:1517-1522.
38. Bartholomaus I., Kawakami N., Odoardi F., Schlager C., Miljkovic D., Ellwart J.W., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
39. Issazadeh S., Lorentzen J.C., Mustafa M.I., Hojeberg B., Mussener A., Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J Neuroimmunol 1996, 69:103-115.
40. Hofstetter H., Gold R., Hartung H.P. Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J 2009, 16:12-18.
41. Chess L., Jiang H. Resurrecting CD8+ suppressor T cells. Nat Immunol 2004, 5:469-471.
42. Bai X.F., Shi F.D., Xiao B.G., Li H.L., van der Meide P.H., Link H. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. J Neuroimmunol 1997, 80:65-75.
43. Wildbaum G., Netzer N., Karin N. Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest 2002, 110:701-710.
44. Hellings N., Raus J., Stinissen P. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action. Autoimmun Rev 2004, 3:267-275.
45. Zang Y.C., Hong J., Rivera V.M., Killian J., Zhang J.Z. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol 2000, 164:4011-4017.
46. Stinissen P., Zhang J., Medaer R., Vandevyver C., Raus J. Vaccination with autoreactive T cell clones in multiple sclerosis: overview of immunological and clinical data. J Neurosci Res 1996, 45:500-511.
47. Correale J., Lund B., McMillan M., Ko D.Y., McCarthy K., Weiner L.P. T cell vaccination in secondary progressive multiple sclerosis. J Neuroimmunol 2000, 107:130-139.